Royalty Report: Medical, Surgical, Supply – Collection: 27345

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 15

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 15

Primary Industries

  • Medical
  • Surgical
  • Supply
  • Device
  • Ophthalmological
  • Technical Know How
  • Tissue
  • Delivery
  • Wound Care

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 27345

License Grant
The Company has been granted three United States patents relating to the use of tissue on a removable backing which cover the sleeve configuration of Peri- Strips, the combination of tissue with a surgical stapling gun, and methods of performing a surgical procedure to remove diseased tissue.
License Property
Patent relates to Peri-Strips Dry covering the application of buttressing material (tissue or other synthetic material) onto a surgical stapler for purposes of reinforcing a surgical fastener suture line utilizing an adhesive substance and a positional and pressure equalization device to accomplish the adherence of the tissue to the surgical suturing device.

IPSCIO Record ID: 289220

License Grant
Licensor grants, under Licensor’s and each of its Affiliates’ respective rights in the Licensed Patents, a non-exclusive, non-transferable, worldwide, irrevocable, perpetual license to make, have made, use, import, export, market, sell, have sold, offer for sale, distribute and otherwise exploit Royalty-Bearing Products within the Orthopedic Field.

The Parties agree to promptly dismiss all claims and counter-claims with this agreement.

License Property
Royalty-Bearing Products means the Accused Products, the Non-Accused Products and any New Product or Other Product that Licensee elects to be a Royalty-Bearing Product; each of the foregoing solely to the extent the manufacture, use, sale, offering for sale, importation, exportation or other exploitation of which in a particular country would, in the absence of the licenses, covenants, releases and immunities granted by Licensor under this Agreement, infringe, contribute to the infringement of, or induce the infringement of any Valid Claim of any patent within the Licensed Patents issued in such country.

The accused products are Magnum I, Magnum II, and, Mini-Magnum.

The patents relate to Suture anchor, Bone suture, Body tissue fastening, Method of positioning body tissue relative to a bone, and, Method and apparatus for use in anchoring a suture.

Field of Use
Orthopedic Field means the branch of medicine that deals with the diagnosis, analysis, treatment, prevention, correction, rehabilitation or study of injuries or disorders of the skeletal system and associated muscles, joints and ligaments.

IPSCIO Record ID: 3610

License Grant
Licensors grant Licensee an exclusive, worldwide, royalty-bearing right and license, with a right to sub-license, to the rights of Licensors under the Patent.
License Property
Products means a diaphragm or patch and improvements thereto for SAVR the 'Patch' and all Patch products and accessories such as holders, strips of pericardium, sizers, sutures and improvements thereto and kits sold for use in a surgical procedure in which the chest is opened to rebuild, reconstruct or remodel the anterior ventricular wall.

IPSCIO Record ID: 29212

License Grant
The Licensee entered into an exclusive License and development Agreement with an Australian University, granting the Company a worldwide exclusive (even as to the university) License, with rights to subLicense, to all the Company’s product candidates and associated know-how based on the University's technology, including the exclusive right to manufacture, use and sell the product candidates. The Company agreed to invest towards development of any Licensed product.
License Property
The University Intellectual Resources Management is focused on developing the key surgical devices that would make noninvasive procedures a reality.  The Licensee is a developmental stage medical device company focused on the development of medical devices that manipulate tissues for endoscopic and minimally invasive surgery for the treatment of obesity, gastroesophageal reflux disease, Barrett's Esophagus, esophageal obstructions, upper gastrointestinal bleeding, hernia formation and other intraperitoneal abnormalities.  The Company’s product portfolio includes a device for endoscopic bariatric surgery (obesity surgery) and endoscopic repair of gastroesophageal reflux disorder (GERD), as well as an endoscopic device for excision and diagnosis of Barrett’s esophagus.

Licensed Patent Rights and Licensed Patents shall mean (1) United States Provisional Patent Application No. 60/698,748 filed July 13, 2005, and titled Suturing System for Transoral Gastroplasty and United States Provisional Patent Application No. 60/742,826 filed December 6, 2005, and titled Systems and Techniques for Transoral Gastroplasty; (2) International Patent Application No. PCT/US04/028516 entitled Suturing Devices and Methods, filed September 2, 2004 (claiming benefit of U.S. Provisional Patent Application Serial No. 60/499,539, filed September 2, 2003; U.S. Provisional Patent Application Serial No. 60/507,837, filed October 1, 2003; and U.S. Provisional Patent Application Serial No. 60/576,510, filed June 3, 2004); (3) any and all Patent Rights under the patents or patent applications for any Additional Technologies and associated Know-How licensed by the Company.

IPSCIO Record ID: 283919

License Grant
The Agreement provides the Company a license to patent rights and other intellectual property related to New Zealand Licensor's products and technologies for use in certain indications.  This License provides for the exclusive supply of ovine rumen and manufacture of Licensee OviTex and OviTex PRS products.
License Property
Licensors Product consist of but not limited to Ovine rumen, the forestomach of a sheep.  It is the source of the biologic material used in our products. In manufacturing our products, Licensee uses biologic material from ovine rumen because of its plentiful supply, optimal biomechanical profile and open collagen architecture that allows for rapid cellular infiltration.

Through this License, Licensee intellectual property broadly covers the development of extracellular matrix scaffolds derived from ovine rumen and methods for isolating these scaffolds from ovine rumen.

OviTex Reinforced Tissue Matrix, or OviTex, addresses unmet needs in hernia repair and abdominal wall reconstruction by combining the benefits of biologic matrices and polymer materials. OviTex PRS, addresses unmet needs in plastic and reconstructive surgery.

OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft tissue repair or reinforcement in plastic and reconstructive surgery.

Field of Use
OviTex Reinforced BioScaffolds (RBSs) are intended for use as a surgical mesh to reinforce and/or repair soft tissue where weakness exists. Indications for use include the repair of hernias and/or abdominal wall defects that require the use of reinforcing or bridging material to obtain the desired surgical outcome.

Licensee is a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Licensee offer a portfolio of advanced reinforced tissue matrices that improve clinical outcomes and reduce overall costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. Licensee products are an innovative solution that integrate multiple layers of minimally-processed biologic material with interwoven polymers in a unique embroidered pattern, which we refer to as a reinforced tissue matrix.

IPSCIO Record ID: 27294

License Grant
The Company has acquired from an undisclosed Licensor the product licenses and product manufacturing rights to Peri-Guard Processed Bovine Pericardium.
License Property
The products are used in a wide variety of surgical procedures, designed to reinforce, reconstruct and repair tissue and prevent leaks of air, blood and other body fluids.

IPSCIO Record ID: 599

License Grant
The Company hereby grants an exclusive, royalty bearing license under the Product Patents and Technology, with the right to sublicense, to make, have made, use, offer for sale and sell the Product in the Licensed Field and in the Territory.
License Property
The Sharp Shooter® device is a disposable surgical device which allows surgeons to accurately place a cannula in the knee against the meniscus and deliver a needle and suture for meniscus repair.
Field of Use
Licensed Field shall mean meniscal tissue repair.

IPSCIO Record ID: 29254

License Grant
The Licensor granted the Licensee an exclusive license (including the right to grant sublicenses) in and to the devices and the technology for the purposes of making, having made, using and selling the Devices.
License Property
The devices relate to ophthalmic applications of fluid jet technology.
Field of Use
Licensed Field of Use means the medical and surgical fields related to ophthalmological applications.

IPSCIO Record ID: 118680

License Grant
Licensor granted us a non-exclusive license to its patent covering excimer laser ablation of tissue.  The terms of the license permit us to sublicense our subsidiaries.
License Property
The excimer laser systems and related products are used to perform procedures that correct common refractive vision disorders such as nearsightedness, farsightedness and astigmatism.
Field of Use
Laser vision correction is a surgical procedure for correcting disorders such as nearsightedness, farsightedness and astigmatism using an excimer laser. This procedure uses ultraviolet laser energy to remove tissue from the surface of, and thus sculpt, the cornea into a predetermined shape. Because the excimer laser is a cold laser, it is possible to ablate, or remove precise amounts of corneal tissue without causing thermal damage to surrounding tissue. The goal of laser vision correction is to eliminate or reduce a persons reliance on corrective eyewear.

IPSCIO Record ID: 27367

License Grant
Licensor of Netherland hereby grants to Licensee of Netherland an exclusive license for the under Patents and Technology to make, have made, use, import, sell, offer to sell or have sold on its behalf product, including the right to sublicense third parties.
License Property
The Company has exclusively licensed its PolyActive polymer biomaterial technology and patents to Matrix; non-allograft bone tissue.

Tissue Adhesion (Barrier); Method for preventing tissue adhesion 08/279,811 5,480,436 525400-99 USA
Tissue Adhesion (Barrier); Method for preventing tissue adhesion 08/078,350 5,508,306 525400-84 USA
Artificial Skin 574654 5,147,401 525400-151 USA
Substrate for treating skin defect (Second PolyActive artificial skin) 08/298,411 Pending 525400-112 USA
Prosthetic Devices formed from materials having bone-bonding properties and uses 08/389,303 Pending 525400-126 USA therefor. Devices of method?
Prosthetic Devices formed from materials having bone-bonding properties and uses 08/089,857 Pending 525400-68 USA therefor. Devices of method?
Polyester ester copolymers as drug delivery matrices 08/699,896 Pending 525400-157 USA

IPSCIO Record ID: 4411

License Grant
The assignment of the intellectual property agreement for International Patent Application No. PCT/IB2010/000797 to Licensee, the Hong Kong affiliate.
License Property
PCT/IB2010/000797 A Device and Method for Lifting Abdominal Wall During Medical Procedure

IPSCIO Record ID: 203427

License Grant
Licensor grants to Company, an affiliate, an exclusive, worldwide, non-transferable license, with the right to sublicense, to the Intellectual Property to make, have made, modify, import, use, offer to sell, sell and have sold Products and perform and have performed processes under the Intellectual Property, solely in the Field.  The parties are entering into a Stock Purchase Agreement of even date.
License Property
The intellectual property and patents include, but are not limited to, Purification of structurally ordered recombinant protein polymers, Construction of synthetic DNA and its use in large polypeptide synthesis, High molecular weight collagen-like protein polymers, Synthetic proteins as implantables, Protein-enriched thennoplastics, and, Tissue Adhesive Using Synthetic Crosslinking.
Field of Use
The Field shall mean human or veterinary applications involving treatment, repair and/or diagnosis of conditions of the spine; provided that with respect to any Intellectual Property covering covalently crosslinked or adhesive protein polymer formulations (including without limitation, drug delivery formulations) the Field shall mean all orthopaedic applications, including treatment or diagnosis of deformities of the musculoskeletal system, which includes all of the bones and cartilages of the body and associated muscle attachments.

The Company is to develop and commercialize an injectable protein-based formulation for the repair of spinal disks damaged either by injury or aging. Based on Licensor's proprietary tissue adhesive technology, the product under development has potential to be an effective outpatient surgical treatment for chronic low back pain.

IPSCIO Record ID: 28651

License Grant
Assignors, two individuals, hereby sell, assign, and transfer exclusively and subject to all of the terms and conditions of this Agreement, their entire right, title, and interest in and to the Device and the Intellectual Property.
License Property
“Applications” shall mean any and all pending patent applications filed by Assignors relating to the Device and any apparatus and/or method for reducing, sizing and/or stabilizing the circumference of a vascular or anatomical structure designed or used by Assignors, including, but not limited to, the following
(a) In the United States, application No. 09/733,224 entitled Annuloplasty System, filed December 8, 2000;
(b) In Canada, application No. 2,197,069 entitled Apparatus for Reducing the Circumference of a Vascular Structure, filed August 10, 1995;
(c) In the European Region, application No. 95929486.9 entitled Apparatus for Reducing the Circumference of a Vascular Structure, filed August 10, 1995; and
(d) In Japan, application No. 507532/1996 entitled Apparatus for Reducing Circumference of Vascular Structure, filed August 10, 1995 and any and all patents and/or patent applications claiming priority thereto, and any and all patents or patent applications in which either Segmed or Dr. Northrup is an inventor, which relate to the Device and/or any apparatus and/or method for reducing, sizing and/or stabilizing the circumference of a vascular or anatomical structure, and any reissues, continuations, divisions, continuations-in-part or extensions thereof, any patents issuing therefrom; and/or any improvements thereto or enhancements thereof which are either wholly or in part owned, invented, controlled, acquired or otherwise assignable by either or both of the Assignors, and any patent applications therefor and any patents issuing therefrom.

“Device” shall mean the apparatus and/or method for reducing, sizing and/or stabilizing the circumference of a vascular or anatomical structure (the “Field”) covered by the Intellectual Property and fully described in the Applications and applications relating to the Patents, and any and all improvements, modifications, derivations, enhancements, technology, Know-how and Documentation related thereto.

Patent relates to a new annuloplasty technology for the repair of mitral and tricuspid heart valves.

“Patents” shall mean the following patents issued to Assignors in the United States, Australia, Taiwan and South Africa
(a) In the United States, U.S. Patent No. 5,593,424 entitled Apparatus and Method for Reducing and Stabilizing the Circumference of a Vascular Structure, issued January 14, 1997, U.S. Patent No. 5,709,695 entitled Apparatus for Reducing the Circumference of a Vascular Structure, issued January 20, 1998, and U.S. Patent No. 5,961,539 entitled Method and Apparatus for Sizing, Stabilizing and/or Reducing the Circumference of an Anatomical Structure, issued October 5, 1999;
(b) In Australia, patent No. 700530 entitled Apparatus for Reducing Circumference of Vascular Structure, filed August 10, 1995;
(c) In Taiwan, patent No. 096871 entitled Apparatus for Reducing the Circumference of a Bodily Structure, filed August 11, 1995; and
(d) In South Africa patent No. 95/6672 entitled Apparatus and Method for Reducing the Circumference of a Vascular Structure, filed August 10, 1995,
and any and all patents and/or patent applications claiming priority thereto, and any and all patents or patent applications in which Assignors are an inventor, which relate to the Device and/or any apparatus or method for reducing, sizing and/or stabilizing the circumference of a vascular or anatomical structure, and any reissues, continuations, divisions, continuations-in-part or extensions thereof, any patents issuing therefrom, and/or any improvements thereto or enhancements thereof which are either wholly or in part owned, invented, controlled, acquired or otherwise assignable by Assignors, and any patent applications therefor and any patents issuing therefrom.

“Trademark” shall mean the mark represented by United States Registration No. 2,108,883 for the “SEGMENT” mark.

IPSCIO Record ID: 1513

License Grant
The Company hereby grants a world-wide, nonexclusive, nontransferable, royalty-bearing license to use the Licensed Patents to manufacture, have manufactured, sell, distribute and market the Licensed Products (soft intraocular lens products) and to practice the inventions covered by the Licensed Patents.
License Property
Licensed Products shall mean any intraocular lens products, and devices used to insert and/or apply the intraocular lens products, made, used or sold for use in a manner which is covered by a Valid Patent Claim of the Licensed Patents. Patent No. 4,573,998 Methods for Implantation of Deformable Intraocular Lenses; Patent No. 4,715,373 Devices for implantation of Deformable Intraocular Lens Structures; Patent No. 4,702,244 Surgical Device for Implantation of a Deformable Intraocular Lens.
Field of Use
The rights granted apply to implantation of lenses.

IPSCIO Record ID: 282939

License Grant
The University hereby grants to Licensee a royalty-bearing, exclusive right and license under Licensed Subject Matter to manufacture, have manufactured, use and sell Licensed Products, to practice any method, process or procedure within the Patent Rights or the Technology Rights, and to otherwise exploit the Licensed Subject Matter, within the Licensed Territory for use within the Licensed Field.
License Property
U.S. 843,485 – Photopolymerizable Biodegradable Hydrogels as Tissue Contracting Materials and Controlled-Release Carriers

Technology Rights shall mean any and all rights in any technical information, know-how, process, procedure, composition, device, method, formula, protocol, technique, software, design, drawing or data relating to biomedical hydrogels or surface coatings which is not covered by the Patent Rights but which is necessary for practicing an invention, discovery or information covered by the Patent Rights, conceived or reduced to practice either prior to the effective date, or after the effective date and arising out of or in connection with the research program, and which Board has or may have the right to license or sublicense to Licensee under this License Agreement.

Field of Use
Licensed Field shall mean treatment of any medical condition of humans including without limitation treatment of post-surgical adhesions and other fibrosis or scarring conditions, treatment by means of leave-behind materials after open and other less invasive surgical procedures (such as localized drug delivery vehicles, adhesives, sealers, glues and polymers) treatment by means of localized drug release, and treatment by arterial plugging after angioplasty or other percutaneous procedures in interentional cardiology by means of angioplasty catheters of any type.

The Licensee develops, manufactures and commercializes synthetic, absorbable, liquid surgical sealants based on the Company's proprietary polymer technology.

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.